Hegner, Björn
Schaub, Theres
Janke, Daniel
Zickler, Daniel
Lange, Claudia
Girndt, Matthias
Jankowski, Joachim
Schindler, Ralf
Dragun, Duska
Funding for this research was provided by:
EC | Seventh Framework Programme (HEALTH-F2-2009-241544, HEALTH-F2-2009-241544, HEALTH-F2-2009-241544)
Gambro Dialysatoren GmbH, Hechingen, Germany
Baxter Deutschland GmbH
Article History
Received: 28 November 2017
Accepted: 6 July 2018
First Online: 14 August 2018
Competing Interests
: R.S. and D.Z. report grants from Gambro. B.H., T.S. and D.D. report grants from the European Union: SysKID (HEALTH-F2-2009-241544). M.G. reports grants from Baxter Inc during the conduct of this study. R.S., D.Z. and B.H. have a licensed patent (US 2015/0110887 A1) “Permselective membrane for treating vascular calcification in chronic hemodialysis patients.”